VEGFA and glioma: Moreover, combined therapy with POL5551 and B20-4.1.1, a VEGF antagonist, reduced glioma invasiveness and vascular density compared to sole treatment with B20-4.1.1 in two individual orthotopic glioma mouse models [157].